Enfusion Stock Market Value
| ENFN Stock | USD 9.00 0.09 1.01% |
| Symbol | Enfusion |
Enfusion Price To Book Ratio
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.572 | Earnings Share 0.04 | Revenue Per Share 2.11 | Quarterly Revenue Growth 0.158 | Return On Assets 0.0374 |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Enfusion 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Enfusion's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Enfusion.
| 04/10/2024 |
| 10/07/2024 |
If you would invest 0.00 in Enfusion on April 10, 2024 and sell it all today you would earn a total of 0.00 from holding Enfusion or generate 0.0% return on investment in Enfusion over 180 days. Enfusion is related to or competes with C3 Ai, Shopify, Workday, Snowflake, Autodesk, and ServiceNow. Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe,... More
Enfusion Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Enfusion's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Enfusion upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.41 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 12.41 | |||
| Value At Risk | (3.55) | |||
| Potential Upside | 3.94 |
Enfusion Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Enfusion's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Enfusion's standard deviation. In reality, there are many statistical measures that can use Enfusion historical prices to predict the future Enfusion's volatility.| Risk Adjusted Performance | 0.0412 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.21) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0834 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enfusion's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Enfusion Backtested Returns
As of now, Enfusion Stock is not too volatile. Enfusion secures Sharpe Ratio (or Efficiency) of 0.0452, which denotes the company had a 0.0452% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Enfusion, which you can use to evaluate the volatility of the firm. Please confirm Enfusion's Mean Deviation of 1.74, coefficient of variation of 2341.58, and Downside Deviation of 2.41 to check if the risk estimate we provide is consistent with the expected return of 0.11%. Enfusion has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.07, which means a somewhat significant risk relative to the market. Enfusion returns are very sensitive to returns on the market. As the market goes up or down, Enfusion is expected to follow. Enfusion right now shows a risk of 2.33%. Please confirm Enfusion downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to decide if Enfusion will be following its price patterns.
Auto-correlation | -0.07 |
Very weak reverse predictability
Enfusion has very weak reverse predictability. Overlapping area represents the amount of predictability between Enfusion time series from 10th of April 2024 to 9th of July 2024 and 9th of July 2024 to 7th of October 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Enfusion price movement. The serial correlation of -0.07 indicates that barely 7.0% of current Enfusion price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.33 |
Enfusion lagged returns against current returns
Autocorrelation, which is Enfusion stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Enfusion's stock expected returns. We can calculate the autocorrelation of Enfusion returns to help us make a trade decision. For example, suppose you find that Enfusion has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Enfusion regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Enfusion stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Enfusion stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Enfusion stock over time.
Current vs Lagged Prices |
| Timeline |
Enfusion Lagged Returns
When evaluating Enfusion's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Enfusion stock have on its future price. Enfusion autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Enfusion autocorrelation shows the relationship between Enfusion stock current value and its past values and can show if there is a momentum factor associated with investing in Enfusion.
Regressed Prices |
| Timeline |
Pair Trading with Enfusion
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enfusion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enfusion will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Enfusion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enfusion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enfusion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enfusion to buy it.
The correlation of Enfusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enfusion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enfusion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Enfusion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Information and Resources on Investing in Enfusion Stock
When determining whether Enfusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enfusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enfusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enfusion Stock:Check out Enfusion Correlation, Enfusion Volatility and Enfusion Alpha and Beta module to complement your research on Enfusion. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Enfusion technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.